| The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study GS Erdal, O Polat, GU Erdem, R Korkusuz, F Hindilerden, M Yilmaz, ... International Journal of Clinical Oncology 26, 826-834, 2021 | 56 | 2021 |
| Evaluation of sleep disorders in nonmetastatic breast cancer patients based on pittsburgh sleep quality index M Yilmaz Journal of Cancer Research and Therapeutics 16 (6), 1274-1278, 2020 | 19 | 2020 |
| Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse event M Yilmaz Journal of Oncology Pharmacy Practice 26 (1), 236-239, 2020 | 18 | 2020 |
| Nivolumab-induced lichen planus M Yilmaz, SG Mese, U Celik Journal of Oncology Pharmacy Practice 26 (3), 758-760, 2020 | 16 | 2020 |
| Hyperprogression after nivolumab for melanoma: a case report M Yilmaz, B Akovali Journal of Oncology Pharmacy Practice 26 (1), 244-251, 2020 | 14 | 2020 |
| Durable response after discontinuation of nivolumab therapy in the absence of disease progression or toxicity with two advanced NSCLC patients M Yilmaz, S Guven Mese Journal of Oncology Pharmacy Practice 26 (3), 761-767, 2020 | 13 | 2020 |
| Dermatological side effects of immunotherapy drugs and targeted cancer therapies: Importance of dermatology and oncology collaboration SGM U Celik, EH Aydemir, B Engin, M C Oba, M Yilmaz Journal of Oncology Pharmacy Practice, 2020 | 11* | 2020 |
| Nivolumab for metastatic uveal melanoma: A multicenter, retrospective study SY Tacar, F Selcukbiricik, M Yilmaz, K Erturk, AM Sarici, I Gulturk, ... Melanoma Research 31 (5), 449-455, 2021 | 10 | 2021 |
| In-home health services as an alternative form of presentation of patient care M Yılmaz, F Sametoğlu, G Akmeşe, A Tak, B Yağbasan, S Gökçay, ... Istanbul Med Journal, 2010 | 10 | 2010 |
| Ribociclib induced acute kidney injury: A case report I Gulturk, M Yilmaz, A Ozmen, SY Tacar, GS Erdal, D Tural Journal of Oncology Pharmacy Practice 27 (8), 2023-2026, 2021 | 9 | 2021 |
| Atypical response patterns in metastatic melanoma and renal cell carcinoma patients treated with nivolumab: A single center experience M Yilmaz Journal of Oncology Pharmacy Practice 27 (5), 1106-1111, 2021 | 6 | 2021 |
| Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? G Ucar, Y Acikgoz, Y Ergun, O Bal, M Yilmaz, S Karakaya, N Akdeniz, ... Cureus 12 (9), 2020 | 6 | 2020 |
| Two different immune related adverse events occured at pancreas after nivolumab in an advanced RCC patient M Yilmaz, A Baran Journal of Oncology Pharmacy Practice 28 (1), 255-258, 2022 | 5 | 2022 |
| Radiation recall dermatitis with dabrafenib and trametinib: A case report M Yilmaz, U Celik, S Hascicek World Journal of Clinical Cases 8 (3), 522, 2020 | 5 | 2020 |
| In patients with type-2 diabetes, diabetes regulation, Hba1c, duration of diabetes, BMI, dyslipidemia, and microalbuminuria compared with macrovascular complications/Tip-2 … CC Gur, H Polat, C Muderrisoglu, E Altunoglu, M Yilmaz Istanbul Medical Journal 14 (4), 243-248, 2013 | 5 | 2013 |
| Relationship between survival outcomes and microsatellite instability, tumor infiltrating lymphocytes and programmed cell death ligand-1 expression in patients with bladder … D Tural, E Akar, HF Baytekin, D Canoglu, M Yilmaz, V Tugcu J buon 26 (5), 2117-25, 2021 | 4 | 2021 |
| Crizotinib for c-MET–amplified advanced NSCLC: a single-center experience SY Tacar, M Yilmaz, B Oz, D Tural Tumori Journal 108 (3), 258-262, 2022 | 3 | 2022 |
| Predictive significance of inflammatory indexes in metastatic nonsmall cell lung cancer patients treated with platinum-doublet chemotherapy M Yilmaz, A Baran, MK Yilmaz Journal of Cancer Research and Therapeutics 18 (1), 220-223, 2022 | 3 | 2022 |
| Is There predictive significance of HALP score in metastatic RCC patients treated with Nivolumab M Yilmaz Eurasian J Medicial Investigation 5, 33-8, 2021 | 3 | 2021 |
| Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAFV600E-mutant metastatic melanoma M Yilmaz, Ş Güven Meşe Journal of Oncology Pharmacy Practice 26 (7), 1754-1758, 2020 | 3 | 2020 |
